Selected research
Industry Research
Unit Drug Dose Delivery System Industry Research Report 2026
Market perspective
The global Unit Drug Dose Delivery System market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Unit Drug Dose Delivery System is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Unit Drug Dose Delivery System is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Unit Drug Dose Delivery System is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Unit Drug Dose Delivery System include Agrado S.A, Amcor, Amcor Limited, Catalent, Inc., Constantia Flexibles Group, Gerresheimer, Huhtamaki Oyj., Klockner Pentaplast Group and Nipro Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Unit Drug Dose Delivery System market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Unit Drug Dose Delivery System Market by Company
Agrado S.A
Amcor
Amcor Limited
Catalent, Inc.
Constantia Flexibles Group
Gerresheimer
Huhtamaki Oyj.
Klockner Pentaplast Group
Nipro Corporation
O.Berk Company, LLC
Omnicell, Inc.
Piramal Glass Limited
R-Pharm Germany GmbH
Schott AG.
SGD Pharma.
Stevanato Group
West Pharmaceutical Services
Wipak Group
Unit Drug Dose Delivery System Segment by Type
Blister Packaging
Vials & Ampoules
Pre-fillable Syringes & Catridges
Others (Pouches, Sticks)
Unit Drug Dose Delivery System Segment by Application
Hospitals
Clinics
Unit Drug Dose Delivery System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Unit Drug Dose Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Unit Drug Dose Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Unit Drug Dose Delivery System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Unit Drug Dose Delivery System manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Unit Drug Dose Delivery System by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Unit Drug Dose Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Blister Packaging
- Vials & Ampoules
- Pre-fillable Syringes & Catridges
- Others (Pouches, Sticks)
Applications
- Hospitals
- Clinics
Companies covered
- Agrado S.A
- Amcor
- Amcor Limited
- Catalent, Inc.
- Constantia Flexibles Group
- Gerresheimer
- Huhtamaki Oyj.
- Klockner Pentaplast Group
- Nipro Corporation
- O.Berk Company, LLC
- Omnicell, Inc.
- Piramal Glass Limited
- R-Pharm Germany GmbH
- Schott AG.
- SGD Pharma.
- Stevanato Group
- West Pharmaceutical Services
- Wipak Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Unit Drug Dose Delivery System Market Size (2021-2032)
- 2.2.2 Global Unit Drug Dose Delivery System Sales (2021-2032)
- 2.2.3 Global Unit Drug Dose Delivery System Market Average Price (2021-2032)
- 2.3 Unit Drug Dose Delivery System by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Blister Packaging
- 2.3.3 Vials & Ampoules
- 2.3.4 Pre-fillable Syringes & Catridges
- 2.3.5 Others (Pouches, Sticks)
- 2.4 Unit Drug Dose Delivery System by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Unit Drug Dose Delivery System Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Unit Drug Dose Delivery System Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Unit Drug Dose Delivery System Revenue of Manufacturers (2021-2026)
- 3.4 Global Unit Drug Dose Delivery System Average Price by Manufacturers (2021-2026)
- 3.5 Global Unit Drug Dose Delivery System Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Unit Drug Dose Delivery System, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Unit Drug Dose Delivery System, Product Type & Application
- 3.8 Global Manufacturers of Unit Drug Dose Delivery System, Established Date
- 3.9 Global Unit Drug Dose Delivery System Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Agrado S.A
- 4.1.1 Agrado S.A Company Information
- 4.1.2 Agrado S.A Business Overview
- 4.1.3 Agrado S.A Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Agrado S.A Unit Drug Dose Delivery System Product Portfolio
- 4.1.5 Agrado S.A Recent Developments
- 4.2 Amcor
- 4.2.1 Amcor Company Information
- 4.2.2 Amcor Business Overview
- 4.2.3 Amcor Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Amcor Unit Drug Dose Delivery System Product Portfolio
- 4.2.5 Amcor Recent Developments
- 4.3 Amcor Limited
- 4.3.1 Amcor Limited Company Information
- 4.3.2 Amcor Limited Business Overview
- 4.3.3 Amcor Limited Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Amcor Limited Unit Drug Dose Delivery System Product Portfolio
- 4.3.5 Amcor Limited Recent Developments
- 4.4 Catalent, Inc.
- 4.4.1 Catalent, Inc. Company Information
- 4.4.2 Catalent, Inc. Business Overview
- 4.4.3 Catalent, Inc. Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Catalent, Inc. Unit Drug Dose Delivery System Product Portfolio
- 4.4.5 Catalent, Inc. Recent Developments
- 4.5 Constantia Flexibles Group
- 4.5.1 Constantia Flexibles Group Company Information
- 4.5.2 Constantia Flexibles Group Business Overview
- 4.5.3 Constantia Flexibles Group Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Constantia Flexibles Group Unit Drug Dose Delivery System Product Portfolio
- 4.5.5 Constantia Flexibles Group Recent Developments
- 4.6 Gerresheimer
- 4.6.1 Gerresheimer Company Information
- 4.6.2 Gerresheimer Business Overview
- 4.6.3 Gerresheimer Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Gerresheimer Unit Drug Dose Delivery System Product Portfolio
- 4.6.5 Gerresheimer Recent Developments
- 4.7 Huhtamaki Oyj.
- 4.7.1 Huhtamaki Oyj. Company Information
- 4.7.2 Huhtamaki Oyj. Business Overview
- 4.7.3 Huhtamaki Oyj. Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Huhtamaki Oyj. Unit Drug Dose Delivery System Product Portfolio
- 4.7.5 Huhtamaki Oyj. Recent Developments
- 4.8 Klockner Pentaplast Group
- 4.8.1 Klockner Pentaplast Group Company Information
- 4.8.2 Klockner Pentaplast Group Business Overview
- 4.8.3 Klockner Pentaplast Group Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Klockner Pentaplast Group Unit Drug Dose Delivery System Product Portfolio
- 4.8.5 Klockner Pentaplast Group Recent Developments
- 4.9 Nipro Corporation
- 4.9.1 Nipro Corporation Company Information
- 4.9.2 Nipro Corporation Business Overview
- 4.9.3 Nipro Corporation Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Nipro Corporation Unit Drug Dose Delivery System Product Portfolio
- 4.9.5 Nipro Corporation Recent Developments
- 4.10 O.Berk Company, LLC
- 4.10.1 O.Berk Company, LLC Company Information
- 4.10.2 O.Berk Company, LLC Business Overview
- 4.10.3 O.Berk Company, LLC Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 O.Berk Company, LLC Unit Drug Dose Delivery System Product Portfolio
- 4.10.5 O.Berk Company, LLC Recent Developments
- 4.11 Omnicell, Inc.
- 4.11.1 Omnicell, Inc. Company Information
- 4.11.2 Omnicell, Inc. Business Overview
- 4.11.3 Omnicell, Inc. Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Omnicell, Inc. Unit Drug Dose Delivery System Product Portfolio
- 4.11.5 Omnicell, Inc. Recent Developments
- 4.12 Piramal Glass Limited
- 4.12.1 Piramal Glass Limited Company Information
- 4.12.2 Piramal Glass Limited Business Overview
- 4.12.3 Piramal Glass Limited Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Piramal Glass Limited Unit Drug Dose Delivery System Product Portfolio
- 4.12.5 Piramal Glass Limited Recent Developments
- 4.13 R-Pharm Germany GmbH
- 4.13.1 R-Pharm Germany GmbH Company Information
- 4.13.2 R-Pharm Germany GmbH Business Overview
- 4.13.3 R-Pharm Germany GmbH Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 R-Pharm Germany GmbH Unit Drug Dose Delivery System Product Portfolio
- 4.13.5 R-Pharm Germany GmbH Recent Developments
- 4.14 Schott AG.
- 4.14.1 Schott AG. Company Information
- 4.14.2 Schott AG. Business Overview
- 4.14.3 Schott AG. Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Schott AG. Unit Drug Dose Delivery System Product Portfolio
- 4.14.5 Schott AG. Recent Developments
- 4.15 SGD Pharma.
- 4.15.1 SGD Pharma. Company Information
- 4.15.2 SGD Pharma. Business Overview
- 4.15.3 SGD Pharma. Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 SGD Pharma. Unit Drug Dose Delivery System Product Portfolio
- 4.15.5 SGD Pharma. Recent Developments
- 4.16 Stevanato Group
- 4.16.1 Stevanato Group Company Information
- 4.16.2 Stevanato Group Business Overview
- 4.16.3 Stevanato Group Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Stevanato Group Unit Drug Dose Delivery System Product Portfolio
- 4.16.5 Stevanato Group Recent Developments
- 4.17 West Pharmaceutical Services
- 4.17.1 West Pharmaceutical Services Company Information
- 4.17.2 West Pharmaceutical Services Business Overview
- 4.17.3 West Pharmaceutical Services Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 West Pharmaceutical Services Unit Drug Dose Delivery System Product Portfolio
- 4.17.5 West Pharmaceutical Services Recent Developments
- 4.18 Wipak Group
- 4.18.1 Wipak Group Company Information
- 4.18.2 Wipak Group Business Overview
- 4.18.3 Wipak Group Unit Drug Dose Delivery System Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Wipak Group Unit Drug Dose Delivery System Product Portfolio
- 4.18.5 Wipak Group Recent Developments
5 Global Unit Drug Dose Delivery System Market Scenario by Region
- 5.1 Global Unit Drug Dose Delivery System Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Unit Drug Dose Delivery System Sales by Region: 2021-2032
- 5.2.1 Global Unit Drug Dose Delivery System Sales by Region: 2021-2026
- 5.2.2 Global Unit Drug Dose Delivery System Sales by Region: 2027-2032
- 5.3 Global Unit Drug Dose Delivery System Revenue by Region: 2021-2032
- 5.3.1 Global Unit Drug Dose Delivery System Revenue by Region: 2021-2026
- 5.3.2 Global Unit Drug Dose Delivery System Revenue by Region: 2027-2032
- 5.4 North America Unit Drug Dose Delivery System Market Facts & Figures by Country
- 5.4.1 North America Unit Drug Dose Delivery System Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Unit Drug Dose Delivery System Sales by Country (2021-2032)
- 5.4.3 North America Unit Drug Dose Delivery System Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Unit Drug Dose Delivery System Market Facts & Figures by Country
- 5.5.1 Europe Unit Drug Dose Delivery System Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Unit Drug Dose Delivery System Sales by Country (2021-2032)
- 5.5.3 Europe Unit Drug Dose Delivery System Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Unit Drug Dose Delivery System Market Facts & Figures by Country
- 5.6.1 Asia Pacific Unit Drug Dose Delivery System Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Unit Drug Dose Delivery System Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Unit Drug Dose Delivery System Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Unit Drug Dose Delivery System Market Facts & Figures by Country
- 5.7.1 South America Unit Drug Dose Delivery System Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Unit Drug Dose Delivery System Sales by Country (2021-2032)
- 5.7.3 South America Unit Drug Dose Delivery System Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Unit Drug Dose Delivery System Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Unit Drug Dose Delivery System Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Unit Drug Dose Delivery System Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Unit Drug Dose Delivery System Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Unit Drug Dose Delivery System Sales by Type (2021-2032)
- 6.1.1 Global Unit Drug Dose Delivery System Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Unit Drug Dose Delivery System Sales Market Share by Type (2021-2032)
- 6.2 Global Unit Drug Dose Delivery System Revenue by Type (2021-2032)
- 6.2.1 Global Unit Drug Dose Delivery System Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Unit Drug Dose Delivery System Revenue Market Share by Type (2021-2032)
- 6.3 Global Unit Drug Dose Delivery System Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Unit Drug Dose Delivery System Sales by Application (2021-2032)
- 7.1.1 Global Unit Drug Dose Delivery System Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Unit Drug Dose Delivery System Sales Market Share by Application (2021-2032)
- 7.2 Global Unit Drug Dose Delivery System Revenue by Application (2021-2032)
- 7.2.1 Global Unit Drug Dose Delivery System Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Unit Drug Dose Delivery System Revenue Market Share by Application (2021-2032)
- 7.3 Global Unit Drug Dose Delivery System Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Unit Drug Dose Delivery System Value Chain Analysis
- 8.1.1 Unit Drug Dose Delivery System Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Unit Drug Dose Delivery System Production Mode & Process
- 8.2 Unit Drug Dose Delivery System Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Unit Drug Dose Delivery System Distributors
- 8.2.3 Unit Drug Dose Delivery System Customers
9 Global Unit Drug Dose Delivery System Analyzing Market Dynamics
- 9.1 Unit Drug Dose Delivery System Industry Trends
- 9.2 Unit Drug Dose Delivery System Industry Drivers
- 9.3 Unit Drug Dose Delivery System Industry Opportunities and Challenges
- 9.4 Unit Drug Dose Delivery System Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst